124 related articles for article (PubMed ID: 17483888)
1. In vitro degradation and release profiles for Poly-dl-lactide film containing paracetamol.
Zhou S; Song B; Li X
J Mater Sci Mater Med; 2007 Aug; 18(8):1623-6. PubMed ID: 17483888
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of controlled release of heparin from swellable crosslinked starch microspheres.
Bajpai AK; Bhanu S
J Mater Sci Mater Med; 2007 Aug; 18(8):1613-21. PubMed ID: 17483909
[TBL] [Abstract][Full Text] [Related]
3. Electrospun fibers of acid-labile biodegradable polymers containing ortho ester groups for controlled release of paracetamol.
Qi M; Li X; Yang Y; Zhou S
Eur J Pharm Biopharm; 2008 Oct; 70(2):445-52. PubMed ID: 18603416
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of composite poly(d,l-lactide)/montmorillonite nanoparticles for controlled delivery of acetaminophen by solvent-displacement method using glass capillary microfluidics.
Othman R; Vladisavljević GT; Thomas NL; Nagy ZK
Colloids Surf B Biointerfaces; 2016 May; 141():187-195. PubMed ID: 26852102
[TBL] [Abstract][Full Text] [Related]
5. Drug release profiles from and degradation of a novel biodegradable polymer, 2,2-bis(2-oxazoline) linked poly(epsilon -caprolactone).
Tarvainen T; Karjalainen T; Malin M; Peräkorpi K; Tuominen J; Seppälä J; Järvinen K
Eur J Pharm Sci; 2002 Sep; 16(4-5):323-31. PubMed ID: 12208463
[TBL] [Abstract][Full Text] [Related]
6. In vitro degradation and release profiles for electrospun polymeric fibers containing paracetanol.
Peng H; Zhou S; Guo T; Li Y; Li X; Wang J; Weng J
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):206-12. PubMed ID: 18691851
[TBL] [Abstract][Full Text] [Related]
7. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
Jain V; Singh R
Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
[TBL] [Abstract][Full Text] [Related]
8. Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.
Kubo W; Miyazaki S; Attwood D
Int J Pharm; 2003 Jun; 258(1-2):55-64. PubMed ID: 12753753
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the hyperbranched polymer Hybrane H1500 for production of matricial controlled-release particles by hot-melt extrusion.
Raviña-Eirín E; Sánchez-Rodríguez B; Gómez-Amoza JL; Martínez-Pacheco R
Int J Pharm; 2014 Jan; 461(1-2):469-77. PubMed ID: 24368108
[TBL] [Abstract][Full Text] [Related]
10. Preparation of acetaminophen capsules containing beads prepared by hot-melt direct blend coating.
Pham L; Christensen JM
Pharm Dev Technol; 2014 Feb; 19(1):91-102. PubMed ID: 23324019
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
12. Formulation and characterization of acetaminophen nanoparticles in orally disintegrating films.
Al-Nemrawi NK; Dave RH
Drug Deliv; 2016; 23(2):540-9. PubMed ID: 25013958
[TBL] [Abstract][Full Text] [Related]
13. In vitro study of drug-eluting stent coatings based on poly(L-lactide) incorporating cyclosporine A - drug release, polymer degradation and mechanical integrity.
Sternberg K; Kramer S; Nischan C; Grabow N; Langer T; Hennighausen G; Schmitz KP
J Mater Sci Mater Med; 2007 Jul; 18(7):1423-32. PubMed ID: 17387586
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application.
Lao LL; Venkatraman SS
J Biomed Mater Res A; 2008 Oct; 87(1):1-7. PubMed ID: 18080309
[TBL] [Abstract][Full Text] [Related]
15. Postfabrication encapsulation of model protein drugs in a negatively thermosensitive hydrogel.
Zhang Y; Zhu W; Wang B; Yu L; Ding J
J Pharm Sci; 2005 Aug; 94(8):1676-84. PubMed ID: 15986466
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres.
Ren J; Yu X; Ren T; Hong H
J Mater Sci Mater Med; 2007 Aug; 18(8):1481-7. PubMed ID: 17387589
[TBL] [Abstract][Full Text] [Related]
17. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles.
Packhaeuser CB; Kissel T
J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938
[TBL] [Abstract][Full Text] [Related]
18. In situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients.
Itoh K; Tsuruya R; Shimoyama T; Watanabe H; Miyazaki S; D'Emanuele A; Attwood D
Drug Dev Ind Pharm; 2010 Apr; 36(4):449-55. PubMed ID: 19788404
[TBL] [Abstract][Full Text] [Related]
19. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
